WASHINGTON — After years of struggling to control the drug middlemen that create pharmacy networks, the federal authorities may lean on states to rein them in — even, doubtlessly, in Medicare. The Division of Justice has till subsequent month to inform a federal appeals court docket the place the administration stands on the difficulty.
Insurers decide what medicine are lined, the place their prospects can receive these medicine, and the way a lot drug prices their prospects should pay for. After years of complaints from unbiased pharmacies, each state and federal lawmakers have turn out to be more and more enthusiastic about opening up pharmacy networks.
Unlock this text by subscribing to STAT+ and revel in your first 30 days free!
